caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1568418101

Herbert JungDO

Family PracticeHammonton, NJI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Herbert Jung's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 16 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
193450
ATLANTICARE REGIONAL MEDICAL CENTER138399
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
110267
Stuart Honick
Podiatry · Hammonton, NJ
4089
Gerald Ukrainski
Cardiology · Hammonton, NJ
2370
VIRTUA OUR LADY OF LOURDES HOSPITAL INC2232
Angelo Luzzi
Podiatry · Hammonton, NJ
2149
Amerigo Falciani
Diagnostic Radiology · Hammonton, NJ
2132
John Saia
Cardiology · Hammonton, NJ
2131
REKANT, STANLEY1936
KENNEDY UNIVERSITY HOSPITAL INC.1520
NPI 12352473701421
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,056
Unique beneficiaries
—
Total services
1,571
Distinct HCPCS
17
Medicare payment
$119K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,769 Family Practice providers in NJ — top quintile (cohort median 715).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
6,415
Beneficiaries
—
Total drug cost
$368K
Distinct drugs
109
Brand share
16.6%
Top prescribed drugs
Atorvastatin Calcium455 claims
Amlodipine Besylate444 claims
Lisinopril265 claims
Levothyroxine Sodium261 claims
Losartan Potassium253 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.